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262 Fear of Progression Questionnaire for caregivers of youth with
cystic ﬁbrosis (FoP-Q/C)
A. Fidika1, S. Mai1, M. Herle1, L. Goldbeck1. 1University Ulm Medical Centre,
Department of Child and Adolescent Psychiatry/Psychotherapy, Ulm, Germany
Objectives: Fear of disease progression (FoP) in parental caregivers of minors with
cystic ﬁbrosis (CF) is associated with distress and adherence to treatment. Measures
for FoP are available for adult patients and their partners, but so far not applicable
for caregivers. We developed a caregiver form of the questionnaire to apply for
parental caregivers and investigated its psychometric properties.
Methods: Sixteen items were derived from the existing versions of the questionnaire
and from interviews with clinical experts in family-oriented psychosocial care.
Psychometric properties were tested in a sample of 50 caregivers (M= 38.4 years;
SD= 6.72; 86% female) being interested to participate in a web-based psychother-
apy for highly distressed caregivers of minors with CF. Internal consistency and
convergent validity to other measures of distress (anxiety, depression) as well
as divergent validity (parental quality of life) and sensitivity for change were
investigated.
Results: Internal consistency was indicated by Cronbach’s a = 0.88, split-half relia-
bility r = 0.82 and odd-even reliability r = 0.92. Moderate positive correlations with
anxiety (r = 0.51; p< 0.01) and depression (r = 0.57; p< 0.01) were found, as well
negative moderate correlations to quality of life (r = −0.54; p< 0.01). A subgroup of
23 participants receiving the web-based cognitive behavioural intervention showed
a signiﬁcant decrease of FoP-score (d = 1.11).
Conclusion: The preliminary psychometric results indicate excellent reliability and
validity, as well as sensitivity to change. The instrument allows the assessment
of FoP in clinical care and research. Further validation in larger samples is
recommended.
263 Parents’ understanding of genetic mutation and the implications
for their child’s CF
S. Parmar1, G. Latchford1,2, A. Duff2,3, T. Lee3. 1University of Leeds, Leeds
Institute of Health Sciences, Leeds, United Kingdom; 2Leeds Teaching Hospitals
NHS Trust, Clinical and Health Psychology, Leeds, United Kingdom; 3Leeds
Teaching Hospitals NHS Trust, Regional Paediatric CF Unit, Leeds, United
Kingdom
Objectives: A major new development in CF treatment are drugs that target
mutation class, so that potential beneﬁts may not − at present − be available
to all patients with CF. This may lead to CF being viewed differently by teams
and families, as a number of conditions rather than one. This study explored the
understanding of parents with young children with CF.
Methods: A short survey asking about knowledge of mutation type and class and
the potential importance of this on symptoms and treatment was circulated to parents
of young children (<5 years) with CF attending the Leeds Regional Paediatric unit.
Results: 22 parents completed the survey. Three knew both of their child’s
mutations, 16 knew one, 3 were unsure. 9 (32%) knew their child’s mutation class.
All knew that both parents were carriers of the CF gene. Most knew that mutation
class had an impact on health and symptom severity in CF, though there was also
confusion with around 1/3 of respondents unsure or believing it made no or little
difference. 11 (64%) felt it might inﬂuence future treatment options, though 8 (36%)
were unsure.
Conclusion: Many parents are broadly aware that mutation class may be important
in terms of severity of CF and future treatment, though many do not know their
child’s mutation type. There is still some uncertainty amongst parents about how
their child’s mutation types will affect what treatments are available for them in the
future.
264 Grandparental knowledge of cystic ﬁbrosis treatment
A. Vertommen1, T. Havermans1, M. Vreys1, I. Claes1, C. Ruelens1,
M. Proesmans1. 1UZ Leuven, CF Centre, Leuven, Belgium
Objectives: To investigate grandparental involvement in the care of their grandchild
with CF and their knowledge of treatment.
Methods: Grandparents attended an informative meeting at the Leuven CF center,
with specialist talks by the pediatrician, nurse, dietician and physiotherapist. A
questionnaire assessed their involvement in care and knowledge before and after
the talks.
Results: Twenty-three grandfathers (GF) (mean age 64) and 30 grandmothers (GM)
(mean age 63) of 25 children (mean age 7.2) participated. Many grandparents
present care for their grandchild once a week or more (17 GM and 16 GF).
Grandparents had received CF information from the parents (51%), the CF as-
sociation (21%), the internet (18%) and other (10%, e.g. books). Table 1 shows a
selection of knowledge questions and the percentage of correct answers before and
after the talks.
Table 1. Knowledge of grandparents
Example item % correct answers
Before talks After talks
Correct use of antibiotics 64 92
Pulmozyme DNAse 56 71
Caloric value of foods 56 92
Caloric need in CF 87 88
Antibiotics and physiotherapy 19 47
Cleaning of nebulizer 94 88
Conclusion: The informative meeting was well attended. Insufﬁcient knowledge
was often related to questions on ‘use of antibiotics’, ‘DNAse’ and ‘caloric value of
foods’. Grandparents corrected their answers on the second questionnaire, showing
the teaching value of the talks. Overall, grandparents’ knowledge of CF treatment
was adequate and they are actively involved in the care of their grandchild making
them important partners for parents and CF teams.
265 Exploring the pre-hospitalisation needs of parents of children
with cystic ﬁbrosis
V.C. Hughes1, S. Phillips2. 1University of Bath, Department of Psychology, Bath,
United Kingdom; 2Bristol Royal Hospital for Children, Psychological Health
Services, Bristol, United Kingdom
Background: Cystic Fibrosis is a life-limiting illness, often requiring repeated
hospital admissions in order to effectively manage symptoms. Hospitalisation can
be stressful for patients and their families. Pre-admission information provision is
crucial in establishing a good basis for patient satisfaction and cooperation.
Objectives: To explore whether families who were admitted to a UK Children’s
Hospital were adequately prepared for their child’s hospital admission.
Methods: Twelve parents whose children had been admitted within the last two
years for routine intravenous antibiotics participated in the study. Data were col-
lected using semi-structured interviews, analysed using inductive thematic analysis.
Results: Four main themes emerged: feeling unprepared; a challenging environ-
ment; interactions with the medical team, and parental role in medical care: relin-
quishing control versus active participation. The ﬁndings demonstrate that parents
need to receive preparatory information; addressing the medical, practical and
psychosocial implications of admission. The results highlight the adverse effects
of inadequate information on the hospital experience. Parents reported feeling
unprepared for the ward and uncertain of their role in care. Parental uncertainty
was exacerbated by perceived difﬁculties with parent–physician communication.
Conclusion: Admission to hospital can be a difﬁcult experience. Providing ade-
quate information is essential in reducing parental stress, inﬂuencing how future
experiences are appraised and managed. Effective physician–parent communication
and opportunities to participate in care will improve parental satisfaction.
